[1] Beers M and Berkow R.  The Merck Manual; 17th Ed.  1999.  Osteoarthritis: 449-451.
 

[2] Pizzorno J, Murray M, Joiner-Bey H.  The Clinicians Handbook of Natural Medicine.  2002; Churchill Livingstone New York.  Osteoarthritis: 364-371.
 

[3] Beers M and Berkow R.  The Merck Manual; 17th Ed.  1999.  Osteoarthritis: 449-451.
 

[4] Beers M and Berkow R.  The Merck Manual; 17th Ed.  1999.  Osteoarthritis: 449-451.
 

[5] Beers M and Berkow R.  The Merck Manual; 17th Ed.  1999.  Osteoarthritis: 449-451.
 

[6] www.aafp.org American Association of Family Practice.  November 2004.
 

[7] Beers M and Berkow R.  The Merck Manual; 17th Ed.  1999.  Osteoarthritis: 449-451.
 

[8] Pizzorno J, Murray M, Joiner-Bey H.  The Clinicians Handbook of Natural Medicine.  2002; Churchill Livingstone New York.  Osteoarthritis: 364-371.
 

[9] Pavelka K et al.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3 year randomized placebo controlled double blind study.  Arch Intern Med.  2002 Oct 14; 162(18): 2113-2123.
 

[10] Reginster JY et al.  Long term effects of glucosamine sulfate on osteoarthritis progression: a randomized placebo controlled clinical trial.  Lancet.  2001 Jan 27; 357(9252): 251-256.
 

[11] Uebelhart D et al.  Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a 1-year randomized double blind multi-center study versus placebo.  Osteoarthritis Cartilage.  2004 Apr; 12(4): 269-276.
 

[12] Pizzorno J, Murray M, Joiner-Bey H.  The Clinicians Handbook of Natural Medicine.  2002; Churchill Livingstone New York.  Osteoarthritis: 364-371.
 

[13] Jonas WB, Rapoza CP, Blair WF.  The effect of niacinamide on osteoarthritis: a pilot study.  Inflamm Res. 1996 Jul; 45(7): 330-334.
 

[14] Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW.  S-adenosylmethionine versus celecoxib for the treatment of osteoarthritis symptoms: a double blind crossover trial.  BMC Musculoskelet Disord.  2004 Feb 26; 5(1): 6.
 

[15] Soeken KL, Lee WL, Bausell RB, Agelli M, Berman BM.  Safety and efficacy of s-adenosylmethionine for osteoarthritis.  J Fam Pract.  2002 May; 51(5): 425-430.
 

[16] Pizzorno J, Murray M, Joiner-Bey H.  The Clinicians Handbook of Natural Medicine.  2002; Churchill Livingstone New York.  Osteoarthritis: 364-371.
 

[17] Machtey I, Ouknine L.  Tocopherol in osteoarthritis: a controlled pilot study.  J Am Geriatr Soc.  1978; 26: 328-330.
 

[18] Scherak O et al.  High dose vitamin E therapy in patients with activated arthritis.  Z Rheumatol.  1990; 49: 369-373.
 

[19] Sowers M, Lachance L.  Vitamins and arthritis: The roles of Vitamins A, C, D and E.  Rheum Dis Clin North Am.  1999 May; 25(2): 315-332.
 

[20] McAlindon TE et al.  Do antioxidant micronutrients protect against the development  and progression of knee osteoarthritis?  Arthritis Rheum.  1996 Apr; 39(4): 648-656.
 

[21] Travers RL, Rennie GC, Newnham RE.  Boron and arthritis: the results of a double blind pilot study.  J Nutr Med.  1990; 1: 127-132.
 

[22] Gagnier JJ, Chrubasik S, Manheimer E.  Harpagophytum procumbens for osteoarthritis and low back pain: a  systematic review.  BMC Complement Altern Med.  2004 Sep 15; 4(1): 13.
 

[23] Wegener T, Lupke NP.  Treatment of patients with arthrosis of the hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC).  Phytother Res.  2003 Dec; 17(10): 1165-1172.
 

[24] Kimmatkar N et al.  Efficacy and tolerability of boswellia serrata extract in treatment of osteoarthritis of the knee: a randomized double blind placebo controlled trial.  Phytomedicine 2003 Jan; 10(1): 3-7.